Bristol-Myers Squibb (BMY)

Must be logged in to add this company to your watchlist.

Click here to login.

BMY - NYSE - 3/12/2010 8:00 PM

25.89
Change -0.07
% Change -0.27%
Market Cap Revenue Growth Profit Margin Cash
$51.29B -4.12% N/A $8.51B
74 / 4569 2486 / 4568 N/A / 4566 88 / 4096

For the December 2009 quarter, Bristol-Myers Squibb spent 47.66% of gross profits on R&D and 22.00% on SGA expenses. Revenues fell 4.12% year-over-year to $5.03B. The company is trading at 4.84 times earnings(PE) and 2.45 times revenue(PSR). At the end of December 2009, Bristol-Myers Squibb had $8.51B in cash on hand and $6.13B in long-term debt. On 01/28/2010, Bristol-Myers Squibb reported net income of $8.03B, with diluted earnings per share of $4.06.

Valuation

Add More Charts

Price

Current stock price.

PE Ratio: 4.84

Price paid for a share relative to the annual income earned.

Price to Sales Ratio: 2.45

Market cap divided by revenue.

Growth & Profitability

Add More Charts

Revenue Growth: -4.12%

Revenue growth year-over-year.

Earnings per Share: $4.06

Portion of profit allocated to each outstanding share of common stock.

Profit Margin

Margin made on every dollar of revenue.

Fundamentals

Add More Charts

Income Statement

Summary of revenues, expenses & profits.

Balance Sheet

Company's assets, liabilities & shareholders' equity at a specific point in time.

Cash Flow

Cash inflows arise from one of three activities - operations, financing, or investing.